Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA Case of Nivolumab-Induced Myositis.AuthorsFox, Eric; Dabrow, Michael; Ochsner, GregAbstractNivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. A case is presented of nivolumab‐induced myositis, an unlisted side effect.SubjectsCREATINE kinase; MONOCLONAL antibodies; MYOSITISPublicationOncologist, 2016, Vol 21, Issue 12, pe3ISSN1083-7159Publication typeLetter to the EditorDOI10.1634/theoncologist.2016-0170